United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Aug 13, 2026 · Filed Aug 14, 2026

On Aug 13, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$504.24 for US$4.79M under a trading plan, leaving 324,443 shares. Filed Aug 14, 2026 (Form 4).

Sold
9,500 shares
Price
US$504.24 average (US$500.08 to US$512.36)
Value
US$4.79M
Holding after
324,443 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Aug 13, 2026Common StockOption exercise9,500US$135.42333,943Indirect
Aug 13, 2026Common StockSale1,253US$500.08332,690Indirect
Aug 13, 2026Common StockSale1,328US$500.93331,362Indirect
Aug 13, 2026Common StockSale1,519US$501.88329,843Indirect
Aug 13, 2026Common StockSale440US$502.93329,403Indirect
Aug 13, 2026Common StockSale160US$503.83329,243Indirect
Aug 13, 2026Common StockSale961US$505.18328,282Indirect
Aug 13, 2026Common StockSale1,679US$506.16326,603Indirect
Aug 13, 2026Common StockSale920US$507.14325,683Indirect
Aug 13, 2026Common StockSale640US$508.76325,043Indirect
Aug 13, 2026Common StockSale200US$509.92324,843Indirect
Aug 13, 2026Common StockSale160US$511.12324,683Indirect
Aug 13, 2026Common StockSale240US$512.36324,443Indirect

Source

View original at SEC

Related